Effect of efflux pump inhibitors on the susceptibility of Mycobacterium avium complex to clarithromycin

被引:10
|
作者
Menichini, Melissa [1 ]
Lari, Nicoletta [1 ]
Rindi, Laura [1 ]
机构
[1] Univ Pisa, Dipartimento Ric Traslaz & Nuove Tecnol Med & Chi, I-56127 Pisa, Italy
来源
JOURNAL OF ANTIBIOTICS | 2020年 / 73卷 / 02期
关键词
RESISTANCE; INTRACELLULARE;
D O I
10.1038/s41429-019-0245-1
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In this study we aimed to evaluate the effect of the combination of clarithromycin and four inhibitors of efflux pumps (EPIs), including berberine (BER), carbonyl cyanide m-chlorophenylhydrazone (CCCP), piperine (PIP) and tetrandrine (TET), against 12 Mycobacterium avium complex clinical isolates. The minimum inhibitory concentration (MIC) of clarithromycin showed at least a fourfold reduction in presence of BER (83% of total isolates), CCCP (67%), PIP (25%) and TET (75%). Our results showed that the EPIs tested are active against both clarithromycin susceptible and resistant isolates. In particular, among the six resistant isolates, TET reversed the resistance phenotype of three strains, BER of two strains, and CCCP and PIP of one strain. Overall, our findings show the importance of these compounds in increasing the efficacy of clarithromycin in MAC clinical isolates.
引用
收藏
页码:128 / 132
页数:5
相关论文
共 50 条
  • [31] ACTIVITY OF CLARITHROMYCIN AGAINST MYCOBACTERIUM-AVIUM COMPLEX INFECTION IN BEIGE MICE
    KLEMENS, SP
    DESTEFANO, MS
    CYNAMON, MH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (11) : 2413 - 2417
  • [32] Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease *
    Adachi, Yuichi
    Tsuyuguchi, Kazunari
    Kobayashi, Takehiko
    Kurahara, Yu
    Yoshida, Shiomi
    Kagawa, Tomoko
    Hayashi, Seiji
    Suzuki, Katsuhiro
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2020, 26 (07) : 676 - 680
  • [33] Prevention of the Selection of Clarithromycin-Resistant Mycobacterium avium-intracellulare Complex
    Jacques Grosset
    Baohong Ji
    [J]. Drugs, 1997, 54 : 23 - 27
  • [34] TOXICITY OF CLARITHROMYCIN IN THE TREATMENT OF MYCOBACTERIUM-AVIUM COMPLEX INFECTION IN A PATIENT WITH AIDS
    DORRELL, L
    ELLERTON, C
    COTTRELL, DG
    SNOW, MH
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 34 (04) : 605 - 606
  • [35] Prevention of the selection of clarithromycin-resistant Mycobacterium avium-intracellulare complex
    Grosset, J
    Ji, BH
    [J]. DRUGS, 1997, 54 (Suppl 2) : 23 - 27
  • [36] A randomized comparison of two clarithromycin doses for treatment of Mycobacterium avium complex infections
    Dautzenberg, B
    TruffotPernot, C
    Hazebroucq, J
    Legris, S
    Guerin, C
    Begelman, C
    Guermonprez, G
    Fievet, MH
    Chastang, C
    [J]. INFECTION, 1997, 25 (01) : 16 - 21
  • [37] MYCOBACTERIUM-AVIUM COMPLEX PAROTID LYMPHADENITIS - SUCCESSFUL THERAPY WITH CLARITHROMYCIN AND ETHAMBUTOL
    GREEN, PA
    VONREYN, CF
    SMITH, RP
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (07) : 615 - 617
  • [38] Clarithromycin prophylaxis for disseminated Mycobacterium avium infection
    File, TM
    Claypoole, DC
    Longstreth, SJ
    Signs, DJ
    Ruby, WH
    Indorf, AS
    [J]. EXPANDING INDICATIONS FOR THE NEW MACROLIDES, AZALIDES, AND STREPTOGRAMINS, 1997, 21 : 544 - 548
  • [39] The use of dual β-lactams to restore susceptibility of Mycobacterium avium complex
    Al-Jabri, Maha Y.
    Dousa, Khalid M.
    Wilson, Brigid M.
    Bonomo, Robert A.
    [J]. JAC-ANTIMICROBIAL RESISTANCE, 2024, 6 (05):
  • [40] INVITRO SUSCEPTIBILITY OF MYCOBACTERIUM-AVIUM COMPLEX TO ANTIBACTERIAL AGENTS
    DAVIS, CE
    CARPENTER, JL
    TREVINO, S
    KOCH, J
    OGNIBENE, AJ
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1987, 8 (03) : 149 - 155